Wrist Extensor MEP Up-conditioning for Individuals With Incomplete Spinal Cord Injury
Launched by MEDICAL UNIVERSITY OF SOUTH CAROLINA · Apr 8, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new way to help individuals with incomplete spinal cord injuries improve their arm movement. Researchers want to learn how training the brain and muscles can strengthen the connections that allow for better wrist movement. They use a special tool called a transcranial magnetic stimulator (TMS), which safely sends a brief magnetic pulse to stimulate the brain and help activate the wrist extensor muscle, the one that helps lift the wrist back. By training this muscle response, the hope is to enhance the ability to move the arm, which could lead to new therapy options for people with spinal cord injuries.
To participate in this study, individuals must have had a spinal cord injury at or above a specific point in the neck (C6), be stable for at least six months, and have some weakness in wrist movement. Participants will need to attend 30 visits over the course of the study, with each visit lasting about 1.5 hours. It's important to note that certain medical conditions, like having metal implants or a history of seizures, may prevent someone from joining the trial. Overall, this study aims to better understand how to support recovery and improve daily function for those living with spinal cord injuries.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. a history of injury to spinal cord at or above C6
- • 2. neurologically stable (\>6 mo post SCI)
- • 3. medical clearance to participate
- • 4. weak wrist extension at least unilaterally
- • 5. expectation that current medication will be maintained without change for at least 3 months. Stable use of anti-spasticity medication (e.g., baclofen, diazepam, tizanidine) is accepted. In participants with bilateral wrist extension weakness, the more severely impaired arm is studied.
- Exclusion Criteria:
- • 1. motoneuron injury
- • 2. medically unstable condition
- • 3. cognitive impairment
- • 4. a history of epileptic seizures
- • 5. metal implants in the cranium
- • 6. implanted biomedical device in or above the chest (e.g., a cardiac pacemaker, cochlear implant)
- • 7. no measurable MEP elicited in the ECR
- • 8. unable to produce any voluntary ECR EMG activity
- • 9. extensive use of functional electrical stimulation to the arm on a daily basis
- • 10. pregnancy (due to changes in posture and potential medical instability).
About Medical University Of South Carolina
The Medical University of South Carolina (MUSC) is a leading academic health center dedicated to advancing medical research and improving patient care through innovative clinical trials. With a strong emphasis on translational medicine, MUSC leverages its extensive resources and expertise to facilitate groundbreaking studies across various medical disciplines. The institution is committed to fostering collaboration among researchers, healthcare professionals, and patients, ensuring that cutting-edge discoveries translate into effective treatments. As a pioneer in health education and research, MUSC plays a vital role in shaping the future of medicine and enhancing health outcomes in the community and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Charleston, South Carolina, United States
Patients applied
Trial Officials
Blair Dellenbach, MSOT
Principal Investigator
Medical University of South Carolina
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials